Market uptake of new antiviral drugs for the treatment of hepatitis C

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

Medicine, Internal Medicine, Pharmacotherapy +17

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

Stephanos J. Hadziyannis · Annals of Internal Medicine · 2004 · 2.8K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

Michael F. Sorrell, Edward A. Belongia, José Costa et al. · Annals of Internal Medicine · 2009 · 834 citations

Medicine, Infectious Diseases, Clinical Epidemiology +16

Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C

Gary L. Davis, John B. Wong, John G. McHutchison et al. · Hepatology · 2003 · 820 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17